ERD

PARC | Partnership for the Assessment of Risks from Chemicals

01-05-2022

-

30-04-2029

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

HBP SGA3 | Human Brain Project Specific Grant Agreement 3

01-04-2020

-

30-09-2023

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

ICEI | Interactive Computing E-Infrastructure for the Human Brain Project

01-01-2018

-

30-09-2023

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

HBP SGA2 | Human Brain Project Specific Grant Agreement 2

01-04-2018

-

31-03-2020

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

HBP SGA1 | Human Brain Project Specific Grant Agreement 1

01-04-2016

-

31-03-2018

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

HBM4EU | European Human Biomonitoring Initiative

01-01-2017

-

30-06-2022

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

ATMO-ACCESS | Solutions for Sustainable Access to Atmospheric Research Facilities

01-04-2021

-

31-03-2025

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

EBRAINS 2.0 | EBRAINS 2.0: A Research Infrastructure to Advance Neuroscience and Brain Health

01-01-2024

-

31-12-2026

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

01-11-2019

-

30-04-2026

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

ACTRIS IMP | Aerosol, Clouds and Trace Gases Research Infrastructure Implementation Project

01-01-2020

-

31-12-2023

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

01-01-2016

-

31-12-2023

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

01-01-2016

-

31-12-2021

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

ONCOSCREEN | A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways

01-01-2023

-

31-12-2026

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

MERIT | Central Bohemia Mobility Programme for Excellence in Research, Innovation and Technology

01-01-2023

-

31-12-2027

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

BEAt-DKD | Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

01-09-2016

-

31-08-2023

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

01-01-2023

-

31-12-2026

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

SISAQOL-IMI | Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

01-01-2021

-

31-12-2024

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

TTV GUIDE TX | PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL

01-05-2021

-

30-04-2026

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

MONALISA | A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

01-01-2024

-

31-12-2028

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

01-12-2019

-

30-11-2025

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

PRISMAP | The European medical isotope programme: Production of high purity isotopes by mass separation

01-05-2021

-

30-04-2025

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

CHIASMA | Accessible Innovative Methods for the Safety & Sustainability Assessment of Chemicals & Materials

01-01-2024

-

31-12-2027

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

OCSEAN | OCeanic and South East Asian Navigators.

01-01-2020

-

31-12-2025

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

T-RAFIC | Training network for tracking and controlling therapeutic immune cells in cancer

01-04-2025

-

31-03-2029

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

01-05-2015

-

31-10-2021

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

INSIGHT | Integrated Models for the Development and Assessment of High Impact Chemicals and Materials

01-01-2024

-

31-12-2027

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

MDS-RIGHT | Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time

01-05-2015

-

31-10-2020

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

PICKED | PersonalIzed medicine in Chronic KidnEy Disease

01-10-2024

-

30-09-2028

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

SAND | Secretion, Autophagy and their role in Neurodegeneration

01-11-2019

-

31-10-2024

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

TENSION | Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial

01-01-2018

-

31-12-2023

Show more information

Organisation MEDIZINISCHE UNIVERSITAT INNSBRUCK

Projects overview

Selected filters:

PARC | Partnership for the Assessment of Risks from Chemicals

HBP SGA3 | Human Brain Project Specific Grant Agreement 3

ICEI | Interactive Computing E-Infrastructure for the Human Brain Project

HBP SGA2 | Human Brain Project Specific Grant Agreement 2

HBP SGA1 | Human Brain Project Specific Grant Agreement 1

HBM4EU | European Human Biomonitoring Initiative

ATMO-ACCESS | Solutions for Sustainable Access to Atmospheric Research Facilities

EBRAINS 2.0 | EBRAINS 2.0: A Research Infrastructure to Advance Neuroscience and Brain Health

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

ACTRIS IMP | Aerosol, Clouds and Trace Gases Research Infrastructure Implementation Project

EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

ONCOSCREEN | A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways

MERIT | Central Bohemia Mobility Programme for Excellence in Research, Innovation and Technology

BEAt-DKD | Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

SISAQOL-IMI | Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

TTV GUIDE TX | PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL

MONALISA | A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

PRISMAP | The European medical isotope programme: Production of high purity isotopes by mass separation

CHIASMA | Accessible Innovative Methods for the Safety & Sustainability Assessment of Chemicals & Materials

OCSEAN | OCeanic and South East Asian Navigators.

T-RAFIC | Training network for tracking and controlling therapeutic immune cells in cancer

FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

INSIGHT | Integrated Models for the Development and Assessment of High Impact Chemicals and Materials

MDS-RIGHT | Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time

PICKED | PersonalIzed medicine in Chronic KidnEy Disease

SAND | Secretion, Autophagy and their role in Neurodegeneration

TENSION | Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial